0.074 HKD
−162.95 M HKD
59.10 M HKD
945.51 M
About EXTRAWELL PHARMACEUTICAL HLDGS
Sector
CEO
Yi Xie
Headquarters
Hong Kong
Website
Founded
1998
FIGI
BBG000BSKPT6
Extrawell Pharmaceutical Holdings Ltd. is an investment company, which engages in the marketing and distribution of pharmaceutical products. It operates through the following segments: Manufacturing, Trading, and Gene Development. The Manufacturing segment includes the development, manufacture, and sale of pharmaceutical products. The Trading segment covers the marketing and distribution of imported pharmaceutical products. The Gene Development segment focuses on the commercial exploitation and development of genome-related technology. The company was founded on December 8, 1998 and is headquartered in Hong Kong.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of 858 is 0.047 HKD — it has decreased by −6.00% in the past 24 hours. Watch EXTRAWELL PHARMACEUTICAL HLDGS stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on HKEX exchange EXTRAWELL PHARMACEUTICAL HLDGS stocks are traded under the ticker 858.
858 stock has risen by 2.17% compared to the previous week, the month change is a −14.55% fall, over the last year EXTRAWELL PHARMACEUTICAL HLDGS has showed a 38.24% increase.
858 stock is 8.70% volatile and has beta coefficient of 0.79. Track EXTRAWELL PHARMACEUTICAL HLDGS stock price on the chart and check out the list of the most volatile stocks — is EXTRAWELL PHARMACEUTICAL HLDGS there?
Today EXTRAWELL PHARMACEUTICAL HLDGS has the market capitalization of 112.33 M, it has increased by 14.58% over the last week.
Yes, you can track EXTRAWELL PHARMACEUTICAL HLDGS financials in yearly and quarterly reports right on TradingView.
858 net income for the last half-year is 100.93 M HKD, while the previous report showed 74.78 M HKD of net income which accounts for 34.98% change. Track more EXTRAWELL PHARMACEUTICAL HLDGS financial stats to get the full picture.
No, 858 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Dec 22, 2024, the company has 159.00 employees. See our rating of the largest employees — is EXTRAWELL PHARMACEUTICAL HLDGS on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. EXTRAWELL PHARMACEUTICAL HLDGS EBITDA is −2.35 M HKD, and current EBITDA margin is −4.50%. See more stats in EXTRAWELL PHARMACEUTICAL HLDGS financial statements.
Like other stocks, 858 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade EXTRAWELL PHARMACEUTICAL HLDGS stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So EXTRAWELL PHARMACEUTICAL HLDGS technincal analysis shows the sell today, and its 1 week rating is neutral. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating EXTRAWELL PHARMACEUTICAL HLDGS stock shows the sell signal. See more of EXTRAWELL PHARMACEUTICAL HLDGS technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.